Condition
MASH clinical trials and research
As of November 12, 2026, Find a Trial lists 9 MASH clinical trials that are recruiting, at sites in 14 countries (most in United States (7), Belgium (1), Czechia (1)). By phase: Phase 2 (3), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 14Countries
Newest MASH clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Resmetirom in children and teens with MASH | Phase 2 | Indianapolis, Indiana | Recruiting | Aug 13, 2026 |
| ALN-CIDEB for adults with fibrotic MASH (phase 2) | Phase 2 | Tucson, Arizona and 23 other locations | Recruiting | Jun 8, 2026 |
| OPK-88006 in Healthy Adults and People with Presumed MASH | Phase 1/2 | Miami, Florida | Recruiting | Apr 6, 2026 |
| Validating lab assays, IV catheter techniques, and devices for endocrine, cardiometabolic, and musculoskeletal conditions | — | Columbia, Missouri | Recruiting | Jul 24, 2025 |
| Prospective NAFLD/NASH patient cohort and biobank | — | Lugano, Canton Ticino | Recruiting | Jul 4, 2025 |
| Endoscopic ultrasound shear wave elastography for measuring liver fibrosis | — | Newport Beach, California and 2 other locations | Recruiting | Sep 19, 2024 |
| Digoxin for NASH with stage 2–3 fibrosis | Phase 2 | New Haven, Connecticut and 1 other locations | Recruiting | Sep 19, 2024 |
| Endoscopic sleeve gastroplasty for people with obesity and MASH | — | Boston, Massachusetts and 1 other locations | Recruiting | Nov 18, 2023 |
| Screening patients at risk for liver disease in Europe | — | Brussels, Vlaams-brabant and 12 other locations | Recruiting | Dec 15, 2022 |
All recruiting trials (9)
-
Resmetirom in children and teens with MASH
This study tests how safe resmetirom is and how it acts in the body of kids aged 6 to 17 who have MASH with liver fibrosis.
-
ALN-CIDEB for adults with fibrotic MASH (phase 2)
This phase 2 study tests ALN-CIDEB versus placebo to see if it can reduce liver fat, injury, and scarring in adults with fibrotic MASH.
-
OPK-88006 in Healthy Adults and People with Presumed MASH
This study tests OPK-88006 to see if it is safe and how it behaves in the body, first in healthy adults and then in people with presumed MASH.
-
Validating lab assays, IV catheter techniques, and devices for endocrine, cardiometabolic, and musculoskeletal conditions
This project will test whether laboratory assays, IV catheter methods, and equipment give consistent, reliable results in adults with or without obesity-related, metabolic, or musculoskeletal conditions.
-
Prospective NAFLD/NASH patient cohort and biobank
This project will collect medical data and blood/tissue samples from adults with NAFLD/NASH to create a long-term resource to help researchers understand disease course and causes.
-
Endoscopic ultrasound shear wave elastography for measuring liver fibrosis
This study will test whether endoscopic ultrasound shear wave elastography and attenuation imaging can estimate liver fibrosis compared with biopsy and FibroScan in adults with suspected MASLD or MASH.
-
Digoxin for NASH with stage 2–3 fibrosis
This trial will see if taking once-daily digoxin helps clear NASH and reduce liver scarring in adults with biopsy-confirmed NASH and stage 2–3 fibrosis.
-
Endoscopic sleeve gastroplasty for people with obesity and MASH
This study will test whether endoscopic sleeve gastroplasty plus lifestyle changes helps adults with obesity and MASH lose weight and improve liver health compared with lifestyle changes alone.
-
Screening patients at risk for liver disease in Europe
This study is trying to find out if screening high-risk patients in Europe for liver disease using simple tests can help doctors identify and better understand conditions like metabolic dysfunction-associated steatotic liver disease.
Related topics
Quick answers
How many MASH clinical trials are recruiting right now?
9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 14 countries. The most sites are in United States (7 trials), Belgium (1 trial), Czechia (1 trial), France (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.